A PHASE II STUDY: TRASTUZUMAB (T) AND VINORELBINE (V) AS FIRST/SECOND LINE IN HER-2 OVEREXPRESSING METASTATIC BREAST CANCER (MBC)


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles